Horizon Kinetics Medical ETF (MEDX)

Assets	$20.22M
Expense Ratio	0.85%
PE Ratio	22.66
Shares Out	569,946
Dividend (ttm)	$0.41
Dividend Yield	1.18%
Ex-Dividend Date	Dec 23, 2025
Payout Frequency	Annual
Payout Ratio	26.52%

Volume	445
Open	34.37
Previous Close	35.10
Day's Range	34.37 - 34.54
52-Week Low	23.46
52-Week High	35.46
Beta	0.54
Holdings	34
Inception Date	Jan 27, 2023

About MEDX

Fund Home Page

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is issued by Horizon Kinetics.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDX
• ETF Provider: Horizon Kinetics

Top 10 Holdings

68.88% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	16.52%
AbbVie Inc.	ABBV	8.30%
Novartis AG ADR	NVSN.MX	7.64%
US BANK MMDA - USBGFS 7	n/a	7.14%
AstraZeneca PLC	AZN	5.63%
Johnson & Johnson	JNJ	5.63%
Bristol-Myers Squibb Company	BMY	4.93%
Ionis Pharmaceuticals, Inc.	IONS	4.84%
Amgen Inc.	AMGN	4.31%
Alnylam Pharmaceuticals, Inc.	ALNY	3.95%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 23, 2025	$0.4088	Dec 24, 2025
Dec 24, 2024	$0.50233	Dec 26, 2024
Dec 27, 2023	$2.88017	Dec 29, 2023

Performance

MEDX had a total return of 23.80% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.62%.